文献速递肝病消化道肿瘤与早癌

长链非编码RNA癌症易感基因9与RNA结合蛋白异质核糖核蛋白L形成复合物并共同调控与AKT信号通路相关的基因

The Long Noncoding RNA Cancer Susceptibility 9 and RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein L Form a Complex and Coregulate Genes Linked to AKT Signaling.
PubMed 文献 · Hepatology · 2018-10-12

研究通过RNA干扰筛选在肝细胞癌(HCC)细胞系中寻找与细胞活力相关的长链非编码RNA(lncRNA),发现癌症易感基因9(CASC9)在HCC中表达上调并与患者总生存相关;CASC9与异质核糖核蛋白L(HNRNPL)形成复合物,共同调控AKT信号通路和DNA损伤感知相关基因。

要点

  • CASC9在HCC细胞系中调控细胞活力,敲低后凋亡增加、增殖减少。
  • HNRNPL是CASC9相互作用蛋白,敲低HNRNPL可模拟CASC9缺失的活力丧失表型。
  • CASC9:HNRNPL复合物影响AKT信号通路和DNA损伤感知,CASC9表达与HCC患者总生存显著相关。

核心结论

  • 研究提供了HCC中与活力相关的lncRNA综合列表,并确定CASC9:HNRNPL复合物为影响AKT信号通路和DNA损伤感知的临床相关lncRNA/蛋白复合物。

研究设计与样本

  • 在肝细胞癌(HCC)细胞系中应用RNA干扰筛选方法寻找与活力相关的lncRNA。
  • 通过RNA亲和纯化和天然RNA免疫沉淀鉴定并验证CASC9相互作用蛋白。
  • 使用稳定同位素标记氨基酸细胞培养(SILAC)蛋白质组学分析CASC9敲低和HNRNPL敲低细胞。
  • 在鸡胚绒毛尿囊膜异种移植模型中测量CASC9敲低后的肿瘤大小。

主要发现

  • CASC9在HCC中较正常肝脏表达上调,并在多个HCC细胞系中调控细胞活力。
  • CASC9敲低导致凋亡增加和增殖减少。
  • HNRNPL敲低模拟CASC9缺失观察到的活力丧失表型。
  • CASC9表达水平在患者来源肿瘤样本中较正常对照组织升高,并与HCC患者总生存显著相关。
  • 在鸡胚绒毛尿囊膜异种移植模型中,CASC9敲低后肿瘤大小减小。

关键数值与推荐

  • 通过CRISPR干扰以及单条小干扰RNA(siRNA)介导和siRNA池介导的CASC9敲低,在多个HCC细胞系中显示CASC9调控细胞活力。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The identification of viability-associated long noncoding RNAs (lncRNAs) might be a promising rationale for new therapeutic approaches in liver cancer. Here, we applied an RNA interference screening approach in hepatocellular carcinoma (HCC) cell lines to find viability-associated lncRNAs. Among the multiple identified lncRNAs with a significant impact on HCC cell viability, we selected cancer susceptibility 9 (CASC9) due to the strength of its phenotype, expression, and up-regulation in HCC versus normal liver. CASC9 regulated viability across multiple HCC cell lines as shown by clustered regularly interspaced short palindromic repeats interference and single small interfering RNA (siRNA)-mediated and siRNA pool-mediated depletion of CASC9. Further, CASC9 depletion caused an increase in apoptosis and a decrease of proliferation. We identified the RNA binding protein heterogeneous nuclear ribonucleoprotein L (HNRNPL) as a CASC9 interacting protein by RNA affinity purification and validated it by native RNA immunoprecipitation. Knockdown of HNRNPL mimicked the loss-of-viability phenotype observed upon CASC9 depletion. Analysis of the proteome (stable isotope labeling with amino acids in cell culture) of CASC9-depleted and HNRNPL-depleted cells revealed a set of coregulated genes which implied a role of the CASC9:HNRNPL complex in AKT signaling and DNA damage sensing. CASC9 expression levels were elevated in patient-derived tumor samples compared to normal control tissue and had a significant association with overall survival of HCC patients. In a xenograft chicken chorioallantoic membrane model, we measured decreased tumor size after knockdown of CASC9. Conclusion: Taken together, we provide a comprehensive list of viability-associated lncRNAs in HCC; we identified the CASC9:HNRNPL complex as a clinically relevant viability-associated lncRNA/protein complex which affects AKT signaling and DNA damage sensing in HCC.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Klingenberg M, Groß M, Goyal A, et al. The Long Noncoding RNA Cancer Susceptibility 9 and RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein L Form a Complex and Coregulate Genes Linked to AKT Signaling. Hepatology. 2018. PMID: 29790588. doi:10.1002/hep.30102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。